These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 9362377

  • 21. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH, Lee CM, Lu SN, Changchien CS, Wang JC, Wang JH, Hung CH, Hu TH.
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [Abstract] [Full Text] [Related]

  • 22. Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis.
    Yuasa R, Takahashi K, Dien BV, Binh NH, Morishita T, Sato K, Yamamoto N, Isomura S, Yoshioka K, Ishikawa T, Mishiro S, Kakumu S.
    J Med Virol; 2000 May; 61(1):23-8. PubMed ID: 10745228
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M, Bartolomé J, Iñigo ER, López-Alcorocho JM, Cotonat T, Carreño V.
    J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
    [Abstract] [Full Text] [Related]

  • 24. [Expression of precore and core proteins of hepatitis B virus in human hepatoma cell line].
    Liu DX, Dai L, Luo KX.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):174-6. PubMed ID: 12390822
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern.
    Jazayeri SM, Dornan ES, Boner W, Fattovich G, Hadziyannis S, Carman WF.
    J Infect Dis; 2004 May 01; 189(9):1634-45. PubMed ID: 15116300
    [Abstract] [Full Text] [Related]

  • 27. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.
    Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH.
    Liver Int; 2004 Feb 01; 24(1):9-15. PubMed ID: 15101995
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B, Mukhopadhya A, Kurian G.
    J Gastroenterol Hepatol; 2008 Nov 01; 23(11):1734-8. PubMed ID: 18713304
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug 01; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of core promotor and precore mutants of hepatitis B virus in thailand by RFLP and sequencing.
    Theamboonlers A, Tangkijvanich P, Jantaradsamee P, Hirsch P, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 1999 Dec 01; 30(4):750-5. PubMed ID: 10928370
    [Abstract] [Full Text] [Related]

  • 35. Transport of hepatitis B virus precore protein into the nucleus after cleavage of its signal peptide.
    Ou JH, Yeh CT, Yen TS.
    J Virol; 1989 Dec 01; 63(12):5238-43. PubMed ID: 2585603
    [Abstract] [Full Text] [Related]

  • 36. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 37. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang JH, Hige S, Kuramitsu T, Suzuki K, Tanaka E, Okada S, Tokita H, Asahina Y, Inoue K, Kakumu S, Okanoue T, Murawaki Y, Hino K, Onji M, Yatsuhashi H, Sakugawa H, Miyakawa Y, Ueda R, Mizokami M.
    Hepatology; 2006 Aug 01; 44(2):326-34. PubMed ID: 16871568
    [Abstract] [Full Text] [Related]

  • 38. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India.
    Chauhan R, Kazim SN, Bhattacharjee J, Sakhuja P, Sarin SK.
    J Med Virol; 2006 Aug 01; 78(8):1047-54. PubMed ID: 16789012
    [Abstract] [Full Text] [Related]

  • 39. Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.
    Cheong JY, Cho SW, Yoo JH, Hong SP, Kim SO, Yoo WD, Kim JH.
    Hepatogastroenterology; 2008 Aug 01; 55(84):1029-33. PubMed ID: 18705323
    [Abstract] [Full Text] [Related]

  • 40. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.
    Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS.
    J Med Virol; 2004 Oct 01; 74(2):237-45. PubMed ID: 15332272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.